Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
First Atlantic announces ONSHORE MAX test work upgraded RPM Zone rock samples into a 67.4% nickel concentrate, grading up to 71.9% nickel and 1.76% cobalt.
-
AUSTIN, Texas, June 10, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: The merging of artificial intelligence, operational intelligence infrastructure and post-quantum cybersecurity is...
-
AUSTIN, Texas, June 08, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: The convergence of artificial intelligence, operational intelligence infrastructure and post-quantum cybersecurity is...
-
Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity Illustrates Why Radoff and Torok’s Short-Term Campaign Risks Disrupting Seer’s Momentum...
-
REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...
-
– LOQTORZI® net revenue of $11.8 million in Q1 2026 – – Patient accrual complete for 1L HCC Phase 2 randomized clinical trial for anti-IL27 casdozokitug, timing for data readouts tracking to...
-
Alation Inc., the knowledge engine powering enterprises to achieve business outcomes introduces Alation AI Governance
-
Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guidance Three presentations at upcoming TIDES USA annual meeting to feature new data for ECO Synthesis...
-
Daraxonrasib demonstrated unprecedented survival benefit in Phase 3 RASolute 302 trial in previously treated metastatic pancreatic cancer; detailed results will be presented in upcoming ASCO Plenary...
-
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025? Affected Soleno Therapeutics, Inc. Investor Summary Who: Soleno Therapeutics, Inc. (NASDAQ: SLNO)What: Securities fraud...